Federal Register / Vol. 73, No. 22 / Friday, February 1, 2008 / Notices 6185 

GSA. The Federal Center was acquired 

in 1941 by the U.S. government and is 

currently used for office, research, and 

administrative purposes by 26 federal 

agencies. There are approximately 4 

million square feet of space in 

approximately 50 active buildings at the 

Federal Center, and there are 

approximately 6,000 on-site employees. 

The site, formerly part of 

unincorporated Jefferson County, 

Colorado, was recently annexed into the 

City of Lakewood. Annexation has no 

affect on the federal ownership or 

management of the site. GSA recently 

sold 65 of the facility the City of 

Lakewood through the federal land 

disposal process for construction of an 

inter-modal transit station and 

relocation of St. Anthony Hospital. GSA 

proposes to implement a new Master 

Site Plan for the Federal Center that will 

address new opportunities for site 

development. The FEIS, prepared to 

comply with the National 

Environmental Policy Act (NEPA), 

evaluates the proposed Master Site Plan 

alternatives and identifies the 

environmental effects associated with 

implementing the proposed alternatives. 

The Draft Master Site Plan and draft 

Environmental Impact Statement 

released in April 2007, evaluated two 

action alternatives, the Federal Quad 

Alternative and the Federal Mall 

Alternative; and a No Action 

Alternative. Under the No Action 

Alternative, GSA would not implement 

a new Master Site Plan for the Federal 

Center. Though currently planned 

upgrades to site infrastructure would 

move forward contingent upon funding, 

existing resources would not be 

leveraged to attract capital to the site, a 

new vision for growth would not be 

established, and the value and appeal of 

the Federal Center site would not be 

maximized. Under the No Action 

alternative, it would become 

increasingly difficult to maintain the 

resources on the site to serve Federal 

tenants and overall community needs. 

During the public review and comment 

period conducted between May and 

June 2007, over 300 hundred individual 

comments were received from 198 

tenants, neighbors, groups, city, state, 

and federal offices. The Federal Quad 

concept, with modifications, is 

identified in the Final Master Site Plan 

and as the preferred alternative named 

in the FEIS. The defining characteristic 

of the Federal Quad Alternative is the 

central ‘‘Quad’’ that would be located in 

the center of the Federal Center site. The 

enhanced streetscapes throughout the 

campus would encourage area 

employees and residents to walk to and 

from transit and into adjacent districts. 

The Quad would be the heart of the plan 

and would be woven into the fabric of 

the surrounding neighborhoods and 

commercial districts via road and land 

use connections. The Quad would be 

surrounded by complementary office 

buildings, including secure federal 

buildings, non-secure federal buildings, 

and research buildings. A total of 227 

acres (or approximately 36 percent of 

the total site) would be designated for 

open space use. The Federal Quad 

Alternative includes a development 

plan with approximately 3.6 million 

gross square feet of new development, 

plus 1,400 residential units, organized 

around a formal open space/park area 

that suggests a university campus 

setting. The primary change in this 

alternative between the Draft Master 

Site Plan and the Final is additional 

residential units in the northwest area of 

the site in the vicinity of the anticipated 

transit-orientated development and 

intermodal station. The modified 

Federal Quad Alternative as presented 

in the Final Master Site Plan for the 

Federal Center reflects GSA’s preferred 

development strategy. 

Dated: January 24, 2008. 

Steven M. Burke, 

Acting Director, General Services 

Administration, DFC Service Center, PBS, 

Rocky Mountain Region. 

[FR Doc. E8–1908 Filed 1–31–08; 8:45 am] 

BILLING CODE 6820–BK–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–50] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medical Records 

Review under the Prospective Payment 

System (PPS) and Supporting 

Regulations in 42 CFR 412.40–412.52 

Use: The Social Security Amendments 

of 1983 (Pub. L. 98–21), requires quality 

improvement organization (QIO) review 

of medical services provided to 

Medicare beneficiaries. Review of 

services under the QIO program can be 

accomplished by individual case review 

and the Clinical Data Abstraction 

Centers (CDACs). Accordingly, QIOs 

must review, at the direction of CMS: (1) 

All anti-dumping referrals; (2) 

beneficiary complaints involving quality 

issues; (3) potential gross and flagrant 

violations of unnecessary admission 

concerns identified during project data 

collection; (4) requests from hospitals 

for higher-weighted DRG adjustments; 

(5) hospital and managed care plan 

issued notices of non-coverage; (6) 

specific codes for assistants at cataract 

surgery; and (7) cases referred by CMS, 

the Office of the Inspector General, the 

Department of Justice, the managed care 

appeals contractor, intermediaries, 

carriers, or the CDACs. Form Number: 

CMS–R–50 (OMB# 0938–0359); 

Frequency: Yearly; Affected Public: 

Private sector—Business or other forprofit and Not-for-profit institutions; 

Number of Respondents: 6,100; Total 

Annual Responses: 276,500; Total 

Annual Hours: 8,280. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786–

1326. 

In commenting on the proposed 

information collections, please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by April 1, 2008: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

mstockstill on PROD1PC66 with NOTICES

6186 Federal Register / Vol. 73, No. 22 / Friday, February 1, 2008 / Notices 

Submission’’ or ‘‘More Search Options’’

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number lll, Room C4–26–

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Dated: January 25, 2008. 

Michelle Shortt, 

Director, Regulations Development Group, 

Office of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. E8–1810 Filed 1–31–08; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

President’s Committee for People With 

Intellectual Disabilities; Notice of 

Quarterly Meeting 

AGENCY: President’s Committee for 

People with Intellectual Disabilities 

(PCPID); Administration for Children 

and Families; Department of Health and 

Human Services. 

ACTION: Notice of Quarterly Meeting. 

DATES: February 15, 2008, from 3:30 

p.m. to 5:30 p.m. EST. The meeting will 

be conducted via conference call and 

will be open to the public using the 

dial-in information provided below. 

ADDRESSES: The conference call may be 

accessed on the date and time indicated 

by dialing 888–677–5720, passcode: 

1397797. 

Agenda: PCPID will meet to finalize 

the 2007 Report to the President and to 

hear a briefing on the final report of the 

Ticket to Work and Work Incentives 

Advisory Panel. 

FOR FURTHER INFORMATION CONTACT: 

Sally D. Atwater, Executive Director, 

President’s Committee for People with 

Intellectual Disabilities, The Aerospace 

Center, Second Floor, West, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447. Telephone: 202–619–0634, 

Fax: 202–205–9591. E-mail: 

satwater@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: PCPID 

acts in an advisory capacity to the 

President and the Secretary of Health 

and Human Services on a broad range 

of topics relating to programs, services 

and supports for persons with 

intellectual disabilities. PCPID, by 

Executive Order, is responsible for 

evaluating the adequacy of current 

practices in programs, services and 

supports for persons with intellectual 

disabilities, and for reviewing legislative 

proposals that impact the quality of life 

experienced by citizens with 

intellectual disabilities and their 

families. 

Dated: January 25, 2008. 

Sally D. Atwater, 

Executive Director, President’s Committee for 

People with Intellectual Disabilities. 

[FR Doc. E8–1809 Filed 1–31–08; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Request for Notification from Industry 

Organizations Interested in 

Participating in the Selection Process 

for a Nonvoting Industry 

Representative on the Blood Products 

Advisory Committee and Request for 

Nominations for a Nonvoting Industry 

Representative on the Blood Products 

Advisory Committee 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting that 

any industry organizations interested in 

participating in the selection of a 

nonvoting industry representative to 

serve on the Blood Products Advisory 

Committee, Center for Biologics 

Evaluation and Research (CBER), notify 

FDA in writing. A nominee may either 

be self-nominated or nominated by an 

organization to serve as a nonvoting 

industry representative. Nominations 

will be accepted for an upcoming 

vacancy on September 30, 2008, 

effective with this notice. 

DATES: Any industry organization 

interested in participating in the 

selection of an appropriate nonvoting 

member to represent industry interests 

must send a letter stating the interest to 

FDA by March 3, 2008, for vacancies 

listed in the notice. Concurrently, 

nomination material for prospective 

candidates should be sent to FDA by 

March 3, 2008. 

ADDRESSES: All letters of interest and 

nominations should be submitted in 

writing to Donald W. Jehn (see FOR

FURTHER INFORMATION CONTACT). 

FOR FURTHER INFORMATION CONTACT: 

Donald W. Jehn, Division of Scientific 

Advisors and Consultants, Center for 

Biologics Evaluation and Research, 

Food and Drug Administration (HFM–

71), 1401 Rockville Pike, Rockville, MD 

20892, 301–827–1277, 

donald.jehn@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

agency requests nominations for a 

nonvoting industry representative to the 

Blood Products Advisory Committee. 

I. Function 

The Blood Products Advisory 

Committee reviews and evaluates 

available data concerning the safety, 

effectiveness, and appropriate use of 

blood products derived from blood and 

serum or biotechnology which are 

intended for the use in the diagnosis, 

prevention, or treatment of human 

diseases, and, as required, any other 

product for which FDA has regulatory 

responsibility. The committee also 

advises the Commissioner of Food and 

Drugs (the Commissioner) on its 

findings regarding the safety, 

effectiveness, and labeling of the 

products, clinical and laboratory studies 

involving such products, the affirmation 

or revocation of biological product 

licenses, and on the quality and 

relevance of FDA’s research program 

which provides the scientific support 

for regulating these agents. 

II. Selection Procedure 

Any blood products industry, 

association, or organization interested in 

the selection of an appropriate 

nonvoting member to represent industry 

interests should send a letter stating that 

interest to the FDA contact (see FOR

FURTHER INFORMATION CONTACT) within 

30 days of publication of this document 

(see DATES). Within the subsequent 30 

days, FDA will send a letter to each 

organization that has expressed an 

interest, attaching a complete list of all 

such organizations and a list of all 

nominees along with their current 

resumes. The letter will also state that 

it is the responsibility of the interested 

organizations to confer with one another 

and to select a primary and alternate 

candidate, within 60 days after the 

receipt of the FDA letter, and the 

primary candidate will serve as the 

nonvoting member to represent industry 

interests for the Blood Products 

Advisory Committee. The interested 

organizations are not bound by the list 

of nominees in selecting a candidate. 

However, if no individual is selected 

within 60 days, the Commissioner will 

select the nonvoting member to 

represent industry interests. 

III. Application Procedure 

Individuals may self nominate and/or 

an organization may nominate one or 

more individuals to serve as a nonvoting 

mstockstill on PROD1PC66 with NOTICES